Exploration of Targeted Anti-tumor Therapy

Open Access Review

Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women

Katarzyna Rygiel

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:602–616

DOI: https://doi.org/10.37349/etat.2021.00066

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

4051 62 1

Open Access Original Article

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type

Chiara Tarantelli ... Francesco Bertoni

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:586–601

DOI: https://doi.org/10.37349/etat.2021.00065

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

6277 116 6

Open Access Original Article

Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates

Tomohiro Fujii ... Yutaka Matsuda

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:576–585

DOI: https://doi.org/10.37349/etat.2021.00064

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

7783 234 12

Open Access Original Article

Alterations in the Ca²⁺ toolkit in oesophageal adenocarcinoma

Alana L. Cutliffe ... John J. Mackrill

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:543–575

DOI: https://doi.org/10.37349/etat.2021.00063

This article belongs to the special issue Calcium Signaling Apparatus in Cancers

Full Text PDF

5424 62 3

Open Access Review

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies

Stefano Cavalieri ... Laura D. Locati

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:522–542

DOI: https://doi.org/10.37349/etat.2021.00062

This article belongs to the special issue Immunotherapy in Cancer Patients

Full Text PDF

6028 107 12

Open Access Review

The clinical advances of proteolysis targeting chimeras in oncology

Hao Xie ... Jason B. Fleming

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:511–521

DOI: https://doi.org/10.37349/etat.2021.00061

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

10910 252 30

Open Access Review

Proteolysis-targeting chimeras and their implications in breast cancer

Angeles C. Tecalco-Cruz ... Alberto Rojas-Ochoa

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:496–510

DOI: https://doi.org/10.37349/etat.2021.00060

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

6536 105 10